On February 8, 2018, we reported Teva's financial results for Q4 and full year 2017, and provided the outlook for 2018.

Kåre Schultz, Teva’s President and CEO, said, “2017 was a challenging year for Teva. Starting 2018 we are focused on meeting our financial obligations and ensuring a much more solid and sustainable business model going forward. 

“Teva remains a recognized world-class leader in global healthcare, delivering unique value through accessible treatments and innovative medicines. By improving our financial profile through stabilization of our operating profit and cash flow, we will be better positioned to continue serving patients worldwide.”

Read the February 8 Earnings press release >

Read Teva’s full Annual Report for 2017 >